Skip to main content

Klinger Shannon Thyme's Form 4 filing

Moderna, Inc. (MRNA) · filed Sep 3, 2026

Accession no.
0001682852-26-000167
Filed
Sep 3, 2026, 4:56 PM ET
Trade date
Sep 1, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $485.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klinger Shannon ThymeCIK 0001866132Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseAcquired+3,471$30.96+$107,462.1677,600Direct
Sep 1, 2026Common StockSSaleDisposed−3,471$139.95−$485,766.4574,129Direct
Sep 1, 2026Common StockMOption exerciseAcquired+2,166––76,295Direct
Sep 1, 2026Common StockFTax withholdingDisposed−1,048$140.34−$147,076.3275,247Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseDisposed−3,471$0.00$034,716Direct
Sep 1, 2026Common StockMOption exerciseDisposed−2,166$0.00$021,661Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)